z-logo
open-access-imgOpen Access
Update of Management of ANCA-Associated Vasculitis
Author(s) -
Tang Hoi San,
S. Yee
Publication year - 2021
Publication title -
journal of clinical rheumatology and immunology
Language(s) - English
Resource type - Journals
eISSN - 2661-3425
pISSN - 2661-3417
DOI - 10.1142/s2661341721300032
Subject(s) - anca associated vasculitis , vasculitis , medicine , immunology , microscopic polyangiitis , intensive care medicine , disease
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is associated with significant morbidity and mortality. Management of AAV is divided into induction of remission and maintenance of remission. Management of AAV has evolved with the aim of improving treatment outcomes and minimizing treatment toxicities. In this article, we will review the latest evidence on the treatment of AAV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here